期刊文献+

靶向黏着斑激酶siRNA表达载体构建及转染Tca8113细胞的沉默效应 被引量:3

Construction of the siRNA expression vector and the silencing influence on focal adhesion kinase gene of Tca8113 cell line
下载PDF
导出
摘要 目的:构建靶向黏着斑激酶(focal adhesion kinase,FAK)基因的小干涉RNA(small interfering RNA,siRNA)质粒表达载体,转染人舌癌细胞Tca8113后观察其对FAK表达的抑制作用。方法:根据siRNA的设计原则,在人FAK mRNA序列中,设计并合成2条特异性靶序列寡核苷酸及2条无关对照序列,经退火成互补双链,再克隆到pGC-SilencerTM-U6/Neo真核表达载体中,构建重组体pSilencer-FAK并进行酶切鉴定;转染重组质粒至Tca8113细胞中,经G418抗性筛选,获得稳定转染细胞系;运用免疫细胞化学和Western-blot鉴定FAK的沉默效应。结果:质粒酶切证实目的寡核苷酸片段已被克隆到pGC-SilencerTM-U6/Neo载体中;pSi-lencer-FAK转染细胞后,FAK基因的表达受到明显抑制。结论:成功构建了针对人FAK的siRNA表达载体,通过转染Tca8113细胞可有效地抑制细胞中FAK的表达。 Objective-To construct the siRNA expression vector of focal adhesion kinase (FAK) gene and inhibit the expression of FAK gene in tongue cancer cell line Tca8113 by RNA interfering technique. Methods:According to the encoding sequence of FAK mRNA, two pieces of oligonucleotide sequences were designed and synthesized. The annealed oligonucleotide fragments were subcloned into pGCSilencer^TM-U6/Neo siRNA expression vector, After being identified by restriction enzyme method, the recombinant pSilencer-FAK plasmids were transfected into Tca8113 cells. The transfected cells were selected by G418 method, Immuocytochemistry and Western blotting were used to evaluate FAK gene silencing efficiency, Results:The oligonucleotide fragments were correctly inserted into pGCSilencerTM-U6/Neo vector. FAK expression of the transfected cells was significantly down-regulated by pSilencer-FAK. Conclusion:The siRNA expression vector of FAK is successfully constructed and FAK expression of Tca8113 cells can be inhibited by RNA interfering technique.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 2008年第1期13-16,共4页 Journal of Practical Stomatology
基金 南京医科大学科技发展基金重点项目(编号:2006025) 江苏省卫生厅科研项目(编号:H200636)
关键词 黏着斑激酶 舌癌细胞 RNA干扰 Focal adhesion kinase Tongue cancer cell RNA interference
  • 相关文献

参考文献9

  • 1McLean GW, Carragher NO, Avizienyte E, et al. The role of focal adhesion kinase in cancer A new therapeutic opportunity[ J]. Nat Rev Cancer, 2005,5(7)- 505 -515.
  • 2江宏兵,田卫东,李声伟,刘磊.口腔鳞癌粘着斑激酶表达与颈淋巴结转移关系的研究[J].实用口腔医学杂志,2003,19(3):199-201. 被引量:5
  • 3Kurenova E, Xu LH, Yang X, et al. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor interacting protein [ J ]. Mol Cell Biol, 2004, 24 (10) : 4361 -4371.
  • 4孙莉萍,翁建,张秀明,张其清.siRNA的化学修饰和临床应用[J].生命的化学,2005,25(4):339-342. 被引量:9
  • 5Shalom-Feuerstein R, Lindenboim L, Stein R, et al. Restoration of sensitivity to anoikis in Ras-transformed rat intestinal epithelial cells by a Ras inhibitor[ J]. Cell Death Differ, 2004, 11(2): 244-247.
  • 6Jiang X, Sinnett-Smith J, Rozengurt E. Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin Ⅱ, LPA and EGF in intestinal epithelial cells [J]. Cell Signal, 2007, 19(5) :1000 - 1010.
  • 7Wu X, Gan B, Yoo Y, et al. FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation[J]. Dev Cell, 2005, 9(2) : 185 - 196.
  • 8Duxbury MS, ho H, Zinner M J, et al. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells [ J ]. Surgery, 2004, 135(5) :555 -562.
  • 9van Nimwegen M J, van de Water B. Focal adhesion kinase: A potential target in cancer therapy [ J ]. Biochem Pharmacol, 2007,73 (5) :597 - 609.

二级参考文献19

  • 1[1]Weiner TM,Lin ET,Craven KJ,et al. Expression of focal adhesion kinaseand invasive cancer. Lancet,1993,342(8878):1024
  • 2[2]Owens LV,Xu LH,Grven KJ,et al. Over expression of the focal adhesion kinaseininvasive human tumors. Cancer Res,1995,55(13) :2752
  • 3[5]Xie B, ZhaoJH, Kitagawa M,et al. Focal adhesion kinase activates statl in integrin mediated cell migration and adhesion. J BiolChem,2001,276(22): 19512
  • 4[6]Sonoda Y, Matsumoto Y,Funakoshi M,etal. Anti-apoptotic role of focal adhesion kinase. J Biol Chem, 2000, 275(21):16309
  • 5[7]Richardson A, Parsons TA. A mechanism for regulation of the adhesion-assoeiated proteintyrosine kinase pp125FAK.Nature, 1996,380(6574) :538
  • 6[8]Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: The role of the invasive tumour front. J Oral Pathol Med,2000,29(7) :291
  • 7[9]Bryne M, Koppang HS, Lilleng R. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol,1992,166(4):375
  • 8Dorsett Y et al, Nat Rev Drug Discov, 2004, 3(4): 318-329.
  • 9Dykxhoom DM et al. Nat Rev Mol Cell Biol, 2003, 4:457-467.
  • 10Amarzguioui M et al. Nucleic Acids Res, 2003, 31:589-595.

共引文献12

同被引文献34

  • 1Wyszynski DF, Beaty TH, Maestri NE. Genetics of nonsyndromic oral clefts revisited [ J ]. Cleft Palate Craniofac J, 1996, 33(5) :406 -417.
  • 2Schutte BC, Murray JC. The many Daces and factors of orofacial clefts[J]. Hum Mol Genet, 1999, 8(10):1853 - 1859.
  • 3Hill L, Murphy M, McDowall M, et al. Maternal drug histories and congenital malformations: Limb reduction defects and oral clefts[ J]. J Epidenniol Community Health, 1988, 42(1):1 -7.
  • 4Hayes C, Werler MM, Willett WC, et al. Case-control study of periconceptional folic acid supplementation and oral clefts[J]. AmJ Epidemiol, 1996, 143(12):1229-1234.
  • 5ltikala PR, Watkins ML, Mulinare J, et al. Maternal multivitamin use and orofacial clefts in offspring[ J ]. Teratology, 2001, 63(2) :79 -86.
  • 6Krapels IP, van Rooij IA, Ocke MC, et al. Maternal nutritional status and the risk for orofacial cleft offspring in humans[J]. JNutr, 2004, 134(11):3106-3113.
  • 7Goyette P, Pai A, Milos R, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR) [J]. MammGenome, 1998, 9(11): 652-656.
  • 8Sean F, Anne M, James L, et al. The influence of 5,10- methylenetetrahydrofolate reductase genotypes on enzyme activity in placental tissue [ J ]. Br J Obstet Gynecol, 1999, 106(6) :1214 - 1218.
  • 9Chen Z, Karaplis AC, Ackerman SL, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition [ J ]. Human Mol Genet, 2001 , 10(5) :433 -443.
  • 10Xiao WL, Shi B, Zheng Q, et al. Nucleofection is highly efficient tor transfecting genes into murine embryonic palatal mesenchymal cells in primary culture[ J]. Int J Oral Maxillofac Surg, 2007, 36(5) :429-434.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部